To illustrate, approximately fifty percent of AD patients seem to have Lewy body pathologies, and the levels of soluble α-synuclein are elevated in the brains of AD patients, which is associated with deteriorating cognitive function [206]. Here, SNCA is linked to Alzheimer disease.